Related Experiment Video
Updated: Jul 7, 2026
10:35
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
[High-dose intravenous immunoglobulin treatment]
1Chilren's Medical Center, Showa University Northern Yokohama Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 12, 2008
Summary
High-dose intravenous immunoglobulin (IVIG) effectively treats acute Kawasaki disease (KD), but some patients resist initial treatment. Early prediction of IVIG resistance in KD is possible using pre-treatment data and available scoring systems.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Cardiology
Context:
- Kawasaki disease (KD) is a critical pediatric illness affecting coronary arteries.
- High-dose intravenous immunoglobulin (IVIG) is a standard acute-stage treatment for KD.
- A significant percentage of patients (15-20%) exhibit resistance to initial IVIG therapy.
Purpose:
- To highlight the effectiveness and safety of IVIG in acute Kawasaki disease.
- To address the challenge of IVIG resistance in KD patients.
- To emphasize the importance of predicting IVIG-resistant cases early.
Summary:
- Initial high-dose IVIG (2 g/kg) and aspirin treatment within nine days of illness onset is standard for Kawasaki disease.
- Despite its efficacy, 15-20% of KD patients do not respond to initial IVIG therapy.
- Predictive scoring systems utilizing pre-treatment and early treatment data can identify patients likely to be resistant to IVIG.
Impact:
- Facilitates timely identification of non-responsive KD patients.
- Enables prompt adjustment of treatment strategies for resistant cases.
- Aims to mitigate the risk of coronary artery abnormalities in non-responders.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...